Resultados de procura - Quentin M. Anstee

Limitar resultados
  1. 1
    Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

    Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research por Quentin M. Anstee, Robert Goldin

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

    The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2 por Christopher P. Day, Quentin M. Anstee

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility

    S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility por Quentin M. Anstee, Christopher P. Day

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment

    Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment por Paola Dongiovanni, Quentin M. Anstee, Luca Valenti

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis

    Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis por Mazen Noureddin, Quentin M. Anstee, Rohit Loomba

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  6. 6
    The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease

    The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease por Marie Boyle, Steven Masson, Quentin M. Anstee

    Publicado 2017
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  7. 7
    Impact of non-invasive biomarkers on hepatology practice: Past, present and future

    Impact of non-invasive biomarkers on hepatology practice: Past, present and future por Quentin M. Anstee, Laurent Castéra, Rohit Loomba

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  8. 8
    Nonalcoholic fatty liver disease

    Nonalcoholic fatty liver disease por Timothy Hardy, Quentin M. Anstee, Christopher P. Day

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Non-alcoholic fatty liver disease: a practical approach to treatment

    Non-alcoholic fatty liver disease: a practical approach to treatment por Jessica Dyson, Quentin M. Anstee, Stuart McPherson

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  10. 10
    Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging

    Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging por Jessica Dyson, Quentin M. Anstee, Stuart McPherson

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  11. 11
    NAFLD-Associated HCC: Progress and Opportunities

    NAFLD-Associated HCC: Progress and Opportunities por Daniel Geh, Quentin M. Anstee, Helen L. Reeves

    Publicado 2021
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  12. 12
    Genetic modifiers of non-alcoholic fatty liver disease progression

    Genetic modifiers of non-alcoholic fatty liver disease progression por Quentin M. Anstee, Ann K. Daly, Christopher P. Day

    Publicado 2011
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  13. 13
    How big a problem is non-alcoholic fatty liver disease?

    How big a problem is non-alcoholic fatty liver disease? por Quentin M. Anstee, Stuart McPherson, C.P. Day

    Publicado 2011
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases

    Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases por Leon A. Adams, Quentin M. Anstee, Herbert Tilg, Giovanni Targher

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  15. 15
    The Global Burden of Liver Disease

    The Global Burden of Liver Disease por Zobair M. Younossi, Grace Lai‐Hung Wong, Quentin M. Anstee, Linda Henry

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  16. 16
    Thrombin and factor Xa link the coagulation system with liver fibrosis

    Thrombin and factor Xa link the coagulation system with liver fibrosis por Ameet Dhar, Fouzia Sadiq, Quentin M. Anstee, Adam Levene, Robert Goldin, Mark Thursz

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease: a qualitative study

    Using the theoretical domains framework to identify barriers and enabling factors to implementation of guidance for the diagnosis and management of nonalcoholic fatty liver disease... por Kate Hallsworth, Stephan U Dombrowski, Stuart McPherson, Quentin M. Anstee, Leah Avery

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease

    Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease por Stuart McPherson, Elsbeth Henderson, Alastair D. Burt, Christopher P. Day, Quentin M. Anstee

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis

    Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis por Helen Jarvis, Hannah O’Keefe, Dawn Craig, Daniel Stow, Barbara Hanratty, Quentin M. Anstee

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  20. 20
    Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice

    Lifestyle Behavior Change in Patients With Nonalcoholic Fatty Liver Disease: A Qualitative Study of Clinical Practice por Leah Avery, Catherine Exley, Stuart McPherson, Michael I. Trenell, Quentin M. Anstee, Kate Hallsworth

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: